Sad mood and changes in behavior after exposure to a traumatic reminder

Author(s):  
Joshua R. Smith

Posttraumatic stress disorder (PTSD) is a trauma- and stressor-related disorder that may affect individuals who have experienced a traumatic event. Symptoms of PTSD include intrusion symptoms, avoidance of stimuli associated with the traumatic event, negative alterations in cognition and mood, and alterations in arousal and reactivity. Intrusion symptoms in children may manifest as repetitive play in which themes from the trauma are expressed. Children are often unaware of the connection between their repetitive play and the trauma. Additionally, children may experience frightening dreams without recognizable content. Compared to adults, youth may be less able to describe traumatic events and complex emotional states. It is not uncommon to be unable to recall specific events about the trauma. The evidence supporting the use of selective serotonin reuptake inhibitors (SSRIs) in youth with PTSD is mixed. Trauma-focused cognitive behavioral therapy (TF-CBT) has the greatest empirical support for pediatric PTSD.

Author(s):  
Kara M. Brown ◽  
Leena P. Mittal

This chapter on posttraumatic stress disorder (PTSD) in the postpartum reviews the disorder that may occur following: a traumatic birth during which the mother is injured: postpartum medical problems such as hemorrhage or the occurrence of a defect or medical complications in the newborn. Symptoms of PTSD include nightmares, intrusive thoughts, flashbacks, hypervigilance, avoidance of triggers, depressed mood, and a pessimistic view of the future. It is important to screen for PTSD after a traumatic birth as women often hesitate to come forward as they feel ashamed, lack insight into symptoms, lack support, or fear reproach. It is essential to attend to any residual physical trauma or pain following the delivery. Cognitive-behavioral therapy is the treatment of choice. Medication may be helpful including selective serotonin reuptake inhibitors and prazosin to help educe nightmares.


2016 ◽  
Vol 33 (S1) ◽  
pp. S513-S513
Author(s):  
H. El Kefi ◽  
W. Abdelghaffar ◽  
A. Baatout ◽  
C. Bechikh Brahim ◽  
W. Krir ◽  
...  

IntroductionPosttraumatic stress disorder (PTSD) has a high prevalence and severe impact in military populations. Cognitive behavioral therapy (CBT) is indicated in this condition but it is a structured therapy that requires patients’ motivation and doctors’ availability.Objectives and aimsAssess feasibility and effectiveness of CBT in a military group with PTSD.MethodsA group of six militaries that witnessed the same traumatic event (an armed attack) and were diagnosed with PTSD were involved in a structured individual session CBT with one therapist. An assessment using the PTSD checklist for DSM (PCL) was performed initially and in halfway therapy. The therapy included an education about PTSD, a cognitive restructuring, a behavioral approach via home tasks and relaxation techniques.ResultsThe initial PCL scores varied from 25 to 55. All patients were initially on sick leave. Five patients had adjunctive antidepressant medications and one patient was only on therapy. Three patients showed no motivation and were excluded after 3 sessions. Two patients have had 7 weekly sessions and were able to return to work in the same place. One patient with severe PTSD had 2 sessions monthly, he had slight clinical improvement and could not come back to military work. The three patients who are still in therapy have improved PCL scores.ConclusionsCBT can be effective in PTSD. The outcome depends on initial severity of PTSD and assiduity.Disclosure of interestThe authors have not supplied their declaration of competing interest.


2000 ◽  
Vol 2 (1) ◽  
pp. 37-43

Posttraumatic stress disorder (PTSD) is a maladaptive, pathological response to a traumatic event which is currently underdiagnosed and undertreated. This results in part from a lack of awareness regarding the prevalence of the disorder. It has been estimated that at least one third of the general population will be exposed to severe trauma throughout their lifetime, out of which approximately 10 % to 20 % develop PTSD. A prevalence of 3 % to 6 % of PTSD in the general population, found in several studies, corresponds well with these figures. Both the type of trauma and the personal characteristics of the individual involved are associated with the probability of developing PTSD. The Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV) gives four diagnostic criteria: (i) exposure and emotional response to a traumatic event; (ii) reexperiencing; (iii) avoidance; and (iv) increased physiological arousal, along with severe impairment in occupational, social, and interpersonal functioning. The rate of comorbidity with other mental disorders is high, particularly for major depression, anxiety disorders, and substance abuse. Different types of psychological intervention, including cognitive-behavioral therapy and a host of pharmacological interventions, have been tried. Selective serotonin reuptake inhibitors (SSRIs) are currently the most widely researched agents with consistent, though modest, therapeutic effects. Other compounds, such as tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) have also been found to be effective, although their use is limited due to side effects. PTSD is a psychobiological phenomenon in response to psychological trauma, which represents maladaptive neurobiological deregulation and psychological dysfunction, and awaits further recognition and research.


2020 ◽  
Vol 7 (1) ◽  
pp. 107-116
Author(s):  
Quanguang Zhang ◽  
◽  
Yong Li ◽  
Lorelei Tucker

Posttraumatic stress disorder (PTSD) is a psychological disorder that can develop after an individual experiences or witnesses a traumatic event. PTSD is startlingly common in veterans, victims of assault, those undergoing extreme medical care, and the clinicians that treat them. This growing mental health crisis has been dramatically exacerbated by the stressors and tragic events of the ongoing global COVID-19 pandemic. In this review, we will discuss the different classes of treatment for PTSD and examine current lines of research in each. First, we explore how the field of psychotherapy approaches PTSD, with focus placed on exposure therapy, cognitive behavioral therapy, and more. We then describe current pharmacological strategies for PTSD treatment and several prominent therapeutic strategies currently undergoing clinical and pre-clinical trials. Next, we investigate novel approaches that integrate principles of psychotherapy with seemingly unconventional elements and discuss how these unique components may impact recovery. Finally, we explore how telemedicine has been implemented to expand access to care, which is particularly critical in a time of social distancing and economic disparity. We hope that by summarizing current clinical practice and outlining cutting-edge research, this review can elucidate the field and highlight gaps in knowledge that merit further investigation that may lead to more effective and accessible treatment for PTSD patients.


CNS Spectrums ◽  
2003 ◽  
Vol 8 (S1) ◽  
pp. 31-39 ◽  
Author(s):  
Dan J. Stein ◽  
Borwin Bandelow ◽  
Eric Hollander ◽  
David J. Nutt ◽  
Ahmed Okasha ◽  
...  

ABSTRACTPosttraumatic stress disorder (PTSD) is a common and disabling condition. In addition to combat-related PTSD, the disorder occurs in civilians exposed to severe traumatic events, with the community prevalence rate for the combined populations reaching as high as 12%. If left untreated, PTSD may continue for years after the stressor event, resulting in severe functional and emotional impairment and a dramatic reduction in quality of life, with negative economic consequences for both the sufferer and society as a whole. Although PTSD is often overlooked, diagnosis is relatively straight-forward once a triggering stressor event and the triad of persistent symptoms—reexperiencing the traumatic event, avoiding stimuli associated with the trauma, and hyperarousal—have been identified. However, comorbid conditions of anxiety and depression frequently hamper accurate diagnosis. Treatment for PTSD includes psychotherapy and pharmacotherapy. The latter includes selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and monoamine oxidase inhibitors. Only SSRls have been proven effective and safe in long-term randomized controlled trials. Current guidelines from the Expert Consensus Panel for PTSD recommend treatment of chronic PTSD for a minimum of 12–24 months.


2017 ◽  
Vol 2 (2) ◽  
pp. 020227
Author(s):  
Julia Müller

Posttraumatic Stress Disorder (PTSD) is a widespread condition, that affects near 20% of individuals, exposed to traumatic event. Moreover, recent studies suggest, that it has a tendency for chronic course and is associated with increased risk of cardiovascular events. According to clinical guidelines as first line therapy for PTSD trauma-focused cognitive-behavioral therapy or eye movement desensitization and reprocessing therapy must be used. In this educational course are presented highlights of 2-day trauma-focused cognitive therapy training, including PTSD symptoms, overall CBT methods overview, theoretical and practical implications.


Sign in / Sign up

Export Citation Format

Share Document